MedCity News

JUNE 1, 2023

If organizations present medical records, cost data, and descriptions of billing codes to patients without providing context or stripping out medical jargon, then the information is potentially subject to regulatory penalties. That means providing more patient-friendly terminology is more than just a compliance checkbox.

Patients 316

Patients Healthcare Healthcare Electronics 316

Fierce Pharma

OCTOBER 25, 2024

Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets with new data readouts.

Patients 222

Patients Competition Marketing 222

MedCity News

JANUARY 28, 2024

While pharmaceutical companies continue to raise list prices year-over-year, we work behind the scenes to fight the trend by driving competition, negotiating with drugmakers and incentivizing the use of less expensive medicines that deliver the same clinical value.

Competition 325

Competition Medicine Pharma Patients 325

MedCity News

NOVEMBER 9, 2022

Gilad said the offering, named Home Smart Clinic, can give customers a clear picture of ROI because of its high utilization and patient engagement rates.

Competition 246

Competition Patients 246

European Pharmaceutical Review

DECEMBER 4, 2024

A new report, ‘ Enhancing the role of UK medicine regulation ’ by the Association of the British Pharmaceutical Industry (ABPI) explores the key role that regulatory excellence has in driving innovation and early treatment access for patients, as well bringing investment into the UK.

Competition 52

Competition Medicine Leads Pharmaceutical 52

Fierce Pharma

JULY 11, 2023

The race for competitive advantage for pharma today is about far more than just innovative new molecules.

Competition 144

Competition Pharma Marketing Patients 144

PharmaVoice

AUGUST 19, 2024

With fewer side effects, the new wave of upcoming drugs could improve patient adherence, and the competition for a large projected market is getting fierce.

Side effects 290

Side effects Competition Marketing Patients 290

MedCity News

AUGUST 12, 2024

FDA approval of Ascendis Pharma’s Yorvipath is just in time for patients with hypoparathyroidism as Takeda Pharmaceutical will soon stop making the only drug therapy for the rare disorder. But competition could come from others, including an AstraZeneca peptide in late-stage development.

FDA 306

FDA Pharma Competition Pharmaceutical 306

MedCity News

MARCH 29, 2024

Given the increasing competition and rising back-office costs, embracing AI-powered revenue cycle automation to boost profitability and achieve operational excellence is more crucial than ever.

Healthcare Provider 223

Healthcare Provider Competition Healthcare Healthcare 223

Healthcare Success

DECEMBER 2, 2024

And, it can increase patient volume and revenue. And when woven into your content marketing strategy, a strong value proposition becomes essential for increasing patient volume and revenue in the healthcare industry. That’s why your value proposition is crucial for attracting new patients and ensuring long-term loyalty.

Patients 59

Patients Marketing Competition Healthcare 59

pharmaphorum

DECEMBER 14, 2022

When patients experience intense emotion, either positive or negative, they are rendered unconscious. But increased competition is on the horizon. Both the physician and the patient have to be registered and the drugs can only come from a primary source through limited distribution. Competition starts to heat up.

Competition 116

Competition FDA Pharmaceutical Marketing 116

MedCity News

JULY 30, 2024

Guardant Health’s Shield, a liquid biopsy that screens for colorectal cancer by analyzing a patient blood sample, will compete against stool-based tests already established in the market. Shield could also face new competition from other liquid biopsy companies.

Marketing 272

Marketing FDA Competition Patients 272

MedCity News

MAY 19, 2023

They alleged that the health system has prevented its workers from being able to advocate for themselves and their patients through “a draconian system of mobility restrictions and widespread labor law violations that lock in sub-competitive pay and working conditions.”

Competition 279

Competition Patients Healthcare Healthcare 279

MedCity News

AUGUST 3, 2022

Alnylam Pharmaceuticals drug Onpattro, an FDA-approved treatment for nerve pain caused by hereditary transthyretin amyloidosis, now has Phase 3 data showing it can also help the much larger group of patients suffering heart problems from the rare protein disease.

FDA 277

FDA Competition Pharmaceutical Patients 277

Fierce Pharma

AUGUST 14, 2024

Bluebird Bio is making progress on the launch of its three approved gene therapies but appears to be trailing Vertex in its competition to attract patients to their respective treatments for sickle | Bluebird Bio is making progress on the launch of its three approved gene therapies but appears to be trailing Vertex in competition to attract patients (..)

Competition 205

Competition Patients 205

European Pharmaceutical Review

OCTOBER 27, 2023

According to The Biosimilar Medicines Group, part of Medicines for Europe, a new report by IQVIA indicates there is a window of opportunity for the EU to foster future-proof biosimilar competition. Failure to attract biosimilar competition The report emphasised that there is a “huge” biosimilar void to 2032, the group shared.

Competition 105

Competition Medicine Marketing Pharmaceutical 105

MedCity News

NOVEMBER 1, 2023

In a letter to Senate leadership, several organizations asked for the passing of legislation that would reform the patent system and improve competition in the prescription drug space.

Prescription 317

Prescription Competition Patients 317

MedCity News

SEPTEMBER 26, 2024

Following a months-long dispute, data platform Particle Health filed an antitrust lawsuit against Epic, alleging that the EHR giant is using its dominance in the market to prevent competition in the payer platform space.

Competition 321

Competition Marketing Patients 321

pharmaphorum

MAY 21, 2024

FDA is asking artificial intelligence teams to develop a digital endpoint tool to study freezing of gait, a symptom of Parkinson’s that can have a serious impact on patients.

Competition 119

Competition FDA Patients 119

European Pharmaceutical Review

SEPTEMBER 4, 2023

to address the potential competitive harm Amgen’s $27.8 Consolidation in the pharmaceutical industry has given companies the power and incentive to engage in exclusionary rebating practices, which can lead to sky-rocketing prices on essential medications,” stated Henry Liu, Director of the FTC’s Bureau of Competition.

Competition 98

Competition Biopharma Pharmaceutical Government 98

MedCity News

AUGUST 10, 2023

The platform comprises an EHR, as well as software for patient engagement, telehealth and revenue cycle management. Suvida’s chief medical officer said Elation beat out the competition due to its focus on both primary care and value-based care.

Healthcare 244

Healthcare Healthcare Competition Management 244

MedCity News

SEPTEMBER 12, 2022

As the biopharma space gets more competitive and the days of blockbuster drugs seem further in the rearview, biopharma companies are investing in digital to find new and innovative ways to differentiate themselves.

Biopharma 246

Biopharma Medical Competition Patients 246

Pharma Marketing Network

APRIL 3, 2025

Imagine a time when pharmaceutical ads simply told patients what to ask their doctor. Today, patient marketing is no longer a one-way street. For pharma marketing executives and brand teams, understanding this evolution is essential to remaining competitive and compliant in a rapidly shifting healthcare environment.

Marketing 52

Marketing Patients Pharma Media 52

Healthcare Success

MARCH 25, 2025

Forward by Stewart Gandolf, Chief Executive Officer At Healthcare Success, we understand that a patients journey often beings with a search query. Symptom search optimization is crucial for: Guiding patient journeys. These symptom-based searches represent the initial touchpoint in the modern patient acquisition funnel.

Healthcare 95

Healthcare Healthcare Healthcare Provider Medical 95

Fierce Pharma

JULY 12, 2023

Fighting for a place in the competitive atopic dermatitis market, Incyte hopes to reach younger patients with its JAK inhibitor cream Opzelura. Fighting for a place in the competitive atopic dermatitis market, Incyte hopes to reach young patients with its JAK inhibitor cream Opzelura.

Safety 180

Safety Competition Marketing Patients 180

World of DTC Marketing

JUNE 22, 2021

SKIMMERS SUMMARY: There is one and only one social responsibility of business–to use its resources and engage in activities designed to increase its profits so long as it stays within the rules of the game, which is to say, engages in open and free competition without deception or fraud. Milton Friedman.

Patients 156

Patients Food and Drug Administration Pharma Government 156

Evolve Your Success

MARCH 12, 2025

Discover how she leveraged her clinical background to drive innovation and improve patient outcomes, particularly in preventing amputations for those with peripheral arterial disease. Despite having no formal sales training, her deep clinical expertise and firsthand understanding of patient care have propelled her to excel in the field.

Medical sales 130

Medical sales Sales Medical Patients 130

Fierce Pharma

SEPTEMBER 13, 2023

The evolution of clinical research has been dependent on the conversion of Healthcare Organizations (HCOs) to clinical research sites, along with the conversion of Healthcare Providers (HCPs) to Pr | Effective site enablement must address several factors, including protocol design, training, patient recruitment and enrollment, and more.

Competition 130

Competition Healthcare Provider Recruitment Training 130

Fierce Pharma

DECEMBER 17, 2024

With Eylea biosimilar competition creeping in and Roches Vabsymo jockeying for market share in key indications, Regeneron is racing to carve out a new market for the high-dose version of its block | High-dose Eylea demonstrated non-inferiority to the original version of the drug in patients with macular edema following retinal vein occlusion, an indication (..)

Competition 173

Competition Marketing FDA Patients 173

PM360

AUGUST 24, 2023

Among the best ways to serve patients and help healthcare providers communicate about a condition or product is with empathetic approaches that mirror where patients are in their lives, and consider their frustrations and discontents as well as what makes them satisfied and in control.

Competition 98

Competition Marketing Healthcare Healthcare 98

LEVO Health

JANUARY 10, 2025

In an increasingly digital healthcare landscape, keeping patients engaged has become a top priority for providers. By integrating game-like elements into patient care, healthcare providers can drive better health outcomes, enhance patient loyalty, and improve overall satisfaction. billion dollars.

Healthcare 52

Healthcare Healthcare Patients Education 52

World of DTC Marketing

JULY 21, 2021

Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. Drug pricing is done by internal teams who look at what the market will bear and the competitive landscape. Second, a physician is not going to prescribe a drug a patient doesn’t need.

Marketing 285

Marketing Prescription Side effects Doctors 285

Eversana Intouch

AUGUST 10, 2023

Limited understanding of the patient or disease. To empower you and your brand to provide the support that rare disease patients and caregivers seek, our experts rounded up insights to help brands identify, engage with, and treat rare patients at an ever-increasing speed to stay competitive. Small populations.

Patients 98

Patients Competition Marketing Healthcare 98

LEVO Health

JANUARY 13, 2025

Artificial intelligence (AI) is rapidly revolutionizing the healthcare industry, reshaping the patient experience in the process. By leveraging AI in patient care, healthcare providers can improve patient outcomes, enhance efficiency, and reduce costs all while providing a more personalized and seamless patient experience.

Patients 52

Patients Healthcare Healthcare Healthcare Provider 52

PM360

MARCH 12, 2025

Nuvera is a leading consulting firm dedicated to designing, building, and measuring patient and HCP treatment experiences for rare diseases, specialty medicines, and cell and gene therapeutics. For 15 years, Nuvera has helped clients enhance specialty product engagement by delivering data-driven patient experience solutions.

Patients 52

Patients Consulting Competition Management 52

eMediWrite

NOVEMBER 15, 2024

In the highly competitive pharmaceutical industry, your brand’s visibility plays a crucial role, i.e., it can make or break your market success. With the right strategies, you can boost your visibility and regain your competitive edge. With the right strategies, you can boost your visibility and regain your competitive edge.

Pharma 52

Pharma Media Competition Education 52

World of DTC Marketing

JULY 12, 2022

Patients on Medicare who don’t qualify for low-income subsidies could see out-of-pocket costs for the drug of over $12,000. Isn’t it time for Congress to finally pass legislation that helps patients? Innovation and Competition Act. Imbruvica, a cancer medication, carries a wholesale price of about $16,000 a month.

Healthcare 227

Healthcare Healthcare Food and Drug Administration Government 227